Monte Rosa Therapeutics, Inc. Profile Avatar - Palmy Investing

Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral mol…

Biotechnology
US, Boston [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Monte Rosa Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Monte Rosa Therapeutics, Inc. can't present revenue by segment

End of GLUE's Analysis
CIK: 1826457 CUSIP: 61225M102 ISIN: US61225M1027 LEI: - UEI: -
Secondary Listings
GLUE has no secondary listings inside our databases.